Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rewinding the Clock with Epigenomics

Published: Wednesday, April 03, 2013
Last Updated: Wednesday, April 03, 2013
Bookmark and Share
How does a single cell give rise to a fully formed organism? Insights from induced pluripotent stem (iPS) cells have helped scientists develop a deeper understanding of this process.

Since scientists discovered how to create iPS cells seven years ago, researchers have begun to see parallels between the steps required to make iPS cells in the dish and the molecular events that unleash a cancer cell. In a review article published this week in Science, three researchers from the Broad Institute and Massachusetts General Hospital – Brad Bernstein, Mario Suvà, and Nicolo Riggi, describe deep insights that have been gained about features shared between oncogenesis (development of cancer) and induced pluripotency as well as directed differentiation (manipulating stem cells to become particular kinds of cells).

Many of these common features are not found within genes. Instead, events occur in the epigenome, which literally translates to “on top of” the genome. Epigenomics looks beyond our DNA sequence at the stable factors that change our genetic instructions.

Bernstein, a Broad associate member and a professor of pathology at Massachusetts General Hospital, has been studying the role of epigenomics in development and human cancer for the last 14 years. Bernstein answered several of our questions about epigenomics back in 2010. Below is an excerpt from our original interview:

Q: Can you give a couple of visible examples of epigenetics in action?

Brad Bernstein: The calico cat is a fun example. Calico cats are always female so they have two X-chromosomes. The different patches of fur color occur because there is a gene for coat color on the X, which is selectively inactivated in clonal patches of cells. The inactivation occurs by chemical modification of the DNA – there is no change in the DNA sequence – so it’s epigenetic. A less fun example is that epigenetic events also contribute to many types of cancer.

Q: Why did you decide to study epigenomics?

BB: I liked that it was uncharted territory. It was also clear early on that the tools of genomics had the potential to transform a field. So it was a good fit for me, and the Broad.

Q: What’s your favorite thing about working at the Broad Institute and Harvard-affiliated hospitals?

BB: I like working with interesting and capable people who think about big problems. There is also a lot of dedication to the mission, and people across the institution are always enthusiastic about moving science forward.

Q: What are a couple of the big questions in science that you would like to see answered in the next ten years?

BB: A big question in our field is the relationship between environment and the epigenome. We know that environmental cues can be remembered for a long-time – for example, in utero starvation can have long-term health consequences. We also know from model organism studies that certain chromatin structures are inherited when cells divide. There is some reason to think these two observations are related. But it’s really not clear at this point. My hope is that new tools for more precise and comprehensive analysis of the epigenome can begin to address this question and eventually help us understand how environment or perhaps even stochastic changes in chromatin contribute to human disease.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Targeting Cancer’s “Queen Bees” with Better Tissue Modeling
In many types of cancer, standard chemotherapy cures only a fraction of patients.
Wednesday, October 30, 2013
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Monday, June 10, 2013
Gene Mismatch Influences Success of Bone Marrow Transplants
Missing gene in donor found to increase recipient's chances of graft-versus-host disease, a common complication of bone marrow transplantation.
Monday, November 30, 2009
A Peek Under the Hood of Embryonic Stem Cells
Scientists discover unique molecular imprints coupled to DNA in mouse embryonic stem cells.
Tuesday, May 02, 2006
Scientific News
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Studies Explore Science of Cardiovascular Diseases
Two studies highlight how basic science research insights are key to future treatment breakthroughs.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Stem Cells Growing 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Stem Cell Transplant Without Radiation or Chemotherapy
Researchers have successfully performed stem cell transplants without using radiation or chemotherapy.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
Inherited Heart Condition Breakthrough
Using stem cells, scientists have created a specific heart condition model, yeilding insights into unexpected disease mechanisms.
Biobank Storage Time Affects Blood Test Results
Study finds storage time of blood samples at a biobank may affect test results as much as patient age.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!